chr5-126541967-G-GAA
Position:
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BS1_Supporting
The NM_001182.5(ALDH7A1):c.*2997_*2998insTT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.0028 ( 0 hom., cov: 0)
Failed GnomAD Quality Control
Consequence
ALDH7A1
NM_001182.5 3_prime_UTR
NM_001182.5 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.632
Genes affected
ALDH7A1 (HGNC:877): (aldehyde dehydrogenase 7 family member A1) The protein encoded by this gene is a member of subfamily 7 in the aldehyde dehydrogenase gene family. These enzymes are thought to play a major role in the detoxification of aldehydes generated by alcohol metabolism and lipid peroxidation. This particular member has homology to a previously described protein from the green garden pea, the 26g pea turgor protein. It is also involved in lysine catabolism that is known to occur in the mitochondrial matrix. Recent reports show that this protein is found both in the cytosol and the mitochondria, and the two forms likely arise from the use of alternative translation initiation sites. An additional variant encoding a different isoform has also been found for this gene. Mutations in this gene are associated with pyridoxine-dependent epilepsy. Several related pseudogenes have also been identified. [provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -1 ACMG points.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00283 (416/146924) while in subpopulation AFR AF= 0.00467 (188/40288). AF 95% confidence interval is 0.00412. There are 0 homozygotes in gnomad4. There are 197 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALDH7A1 | NM_001182.5 | c.*2997_*2998insTT | 3_prime_UTR_variant | 18/18 | ENST00000409134.8 | NP_001173.2 | ||
ALDH7A1 | NM_001201377.2 | c.*2997_*2998insTT | 3_prime_UTR_variant | 18/18 | NP_001188306.1 | |||
ALDH7A1 | NM_001202404.2 | c.*2997_*2998insTT | 3_prime_UTR_variant | 16/16 | NP_001189333.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALDH7A1 | ENST00000409134.8 | c.*2997_*2998insTT | 3_prime_UTR_variant | 18/18 | 1 | NM_001182.5 | ENSP00000387123 | P4 | ||
ALDH7A1 | ENST00000635851.1 | c.1564-980_1564-979insTT | intron_variant | 5 | ENSP00000490819 | |||||
ALDH7A1 | ENST00000637782.1 | c.1565+4356_1565+4357insTT | intron_variant | 5 | ENSP00000490024 |
Frequencies
GnomAD3 genomes AF: 0.00284 AC: 417AN: 146860Hom.: 0 Cov.: 0
GnomAD3 genomes
AF:
AC:
417
AN:
146860
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0AC: 0AN: 0Hom.: 0 Cov.: 0AC XY: 0AN XY: 0
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AC:
0
AN:
0
Hom.:
Cov.:
0
AC XY:
0
AN XY:
0
GnomAD4 genome AF: 0.00283 AC: 416AN: 146924Hom.: 0 Cov.: 0 AF XY: 0.00276 AC XY: 197AN XY: 71322
GnomAD4 genome
AF:
AC:
416
AN:
146924
Hom.:
Cov.:
0
AF XY:
AC XY:
197
AN XY:
71322
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Pyridoxine-dependent epilepsy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at